Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eddingpharm to sell ALK-Abello's allergy products in China

Executive Summary

ALK-Abello AS (allergy-focused pharma division of Chr. Hansen Holding AS) granted Eddingpharm International Holdings Ltd. (nutrition, oncology, antibiotics, and respiratory therapies) exclusive rights to sell its Soluprick SQ allergy test and Alutard SQ allergy immunotherapy in China for seven years.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies